AKT1 and neoplasm: In highly transformed tumor cells, rapamycin-mediated mTORC1 inhibition triggers activation of mTORC2, promoting AKT phosphorylation at Ser473.35 Inhibition of p70S6K phosphorylation in rapamycin-treated SW480 cells correlated with increased AKT phosphorylation (Figure 2b).